3 ms·
https://www.fda.gov/news-events/press-announcements/fda-approves-new-nasal-spray-medication-treatment-resistant-depression-available-only-certified https://www.
by ghotli 5y ago
https://www.fda.gov/news-events/press-announcements/fda-approves-new-nasal-spray-medication-treatment-resistant-depression-available-only-certified https://www.fda.gov/news-events/press-announcements/fda-appr...
I think it might be further along than your comment suggests. "site:nih.gov esketamine" if you want to peruse what's been done
- rsj_hn 5y agoThanks for this info. Yes, this is farther along than I expected!
- goatsi 5y agoThat's only for one of the isomers of ketamine (rather than the mixture of two used in ketamine clinics), and only for using a nasal spray. That is because the drug company has a patent for using that specific isomer in a nasal spray. None of the esketamine research can be used as evidence for regular (off patent) ketamine. It will need it's own studies. https://qz.com/1889308/why-isnt-ketamine-approved-as-an-antidepressant/ https://qz.com/1889308/why-isnt-ketamine-approved-as-an-anti...